FDA PMA FDA Class 3 Approved 🇺🇸 United States

Implanted Phrenic Nerve Stimulator For Central Sleep Apnea

PMA: P160039 · Supplement: S006 · Decision Jul 28, 2021
Classifications
1
FEI Numbers
3
Registration Numbers
3

Basic Information

Device Name
Implanted Phrenic Nerve Stimulator For Central Sleep Apnea
Trade Name
remede System
PMA Number
P160039
Supplement Number
S006
Device Class
FDA Class 3
Product Code
PSR
Generic Name
Implanted phrenic nerve stimulator for central sleep apnea
Medical Specialty
Unknown
Advisory Committee
Anesthesiology
Decision
Approved
Decision Code
APPR
Decision Date
July 28, 2021
Date Received
January 19, 2021
Supplement Type
Normal 180 Day Track
Supplement Reason
Change Design/Components/Specifications/Material
Expedited Review
N

Advisory Committee Statement

Approval for reducing the IPG size, increasing the IPG battery longevity, reducing the number of set screw connections between the lead terminal and IPG header, and improving features within the Remede Programer software application and the remede Reports application.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
PSR Implanted Phrenic Nerve Stimulator For Central Sleep Apnea